037. Could somatostatin enhance the outcomes of chemotherapeutic treatment in small-cell carcinoma (SCLC)?

OBJECTIVE: Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Furthermore, somatostatin (SST) receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G prot...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Dis
Auteurs principaux: Domvri, Kalliopi, Bougiouklis, Dimitrios, Zarogoulidis, Paul, Porpodis, Konstantinos, Xristoforidis, Manolis, Liaka, Alexandra, Eleutheriadou, Ellada, Organtzis, Ioannis, Kyriazis, George, Malecki, Bianka, Zarogoulidis, Konstantinos
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2015
Sujets:
The Pan Hellenic Congress Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332059/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB037
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires